Literature DB >> 19204646

Clinical definition of COPD exacerbations and classification of their severity.

Gaetano Caramori1, Ian M Adcock, Alberto Papi.   

Abstract

A standardized definition of chronic obstructive pulmonary disease (COPD) exacerbation still represents an unmet need in respiratory medicine; definitions currently rely on clinical empiricism with little evidence-based scientific support. Exacerbations of COPD are certainly clear events in the mind of practicing physicians. However, when one tries to provide simple concepts such as their definition and classification of severity, one realizes how little we know. Current symptom- and event-based definitions of a COPD exacerbation, as well as the classifications of the severity of COPD exacerbations, all have their own limitations. Efforts to assess the efficacy of new therapies in the treatment and prevention of COPD exacerbations have been hampered by the lack of a widely agreed upon and consistently used definition. There is a need for greater investment in research on COPD exacerbations in order to promote a better understanding of COPD exacerbations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204646     DOI: 10.1097/SMJ.0b013e3181836b73

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  10 in total

Review 1.  The empirical foundations of telemedicine interventions for chronic disease management.

Authors:  Rashid L Bashshur; Gary W Shannon; Brian R Smith; Dale C Alverson; Nina Antoniotti; William G Barsan; Noura Bashshur; Edward M Brown; Molly J Coye; Charles R Doarn; Stewart Ferguson; Jim Grigsby; Elizabeth A Krupinski; Joseph C Kvedar; Jonathan Linkous; Ronald C Merrell; Thomas Nesbitt; Ronald Poropatich; Karen S Rheuban; Jay H Sanders; Andrew R Watson; Ronald S Weinstein; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2014-06-26       Impact factor: 3.536

2.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

3.  Direct costs of chronic obstructive pulmonary disease among managed care patients.

Authors:  Anand A Dalal; Laura Christensen; Fang Liu; Aylin A Riedel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

4.  Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial.

Authors:  Emmylou Beekman; Ilse Mesters; Erik J M Hendriks; Jean W M Muris; Geertjan Wesseling; Silvia M A A Evers; Guus M Asijee; Annemieke Fastenau; Hannah N Hoffenkamp; Rik Gosselink; Onno C P van Schayck; Rob A de Bie
Journal:  BMC Pulm Med       Date:  2014-04-26       Impact factor: 3.317

5.  Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.

Authors:  Jadwiga A Wedzicha; Nanshan Zhong; Masakazu Ichinose; Michael Humphries; Robert Fogel; Chau Thach; Francesco Patalano; Donald Banerji
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-19

Review 6.  The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.

Authors:  Timothy E Albertson; Samuel Louie; Andrew L Chan
Journal:  J Am Geriatr Soc       Date:  2010-03       Impact factor: 5.562

Review 7.  Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies.

Authors:  Wilhelmine H Meeraus; Bailey M DeBarmore; Hana Mullerova; William A Fahy; Victoria S Benson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-24

8.  Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.

Authors:  Zaurbek Aisanov; Chunxue Bai; Otto Bauerle; Federico D Colodenco; Charles Feldman; Shu Hashimoto; Jose Jardim; Christopher K W Lai; Rafael Laniado-Laborin; Gilbert Nadeau; Abdullah Sayiner; Jae Jeong Shim; Ying Huang Tsai; Richard D Walters; Grant Waterer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-04-05

Review 9.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28

10.  Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.

Authors:  Jie Zhu; Patrick Mallia; Joseph Footitt; Yusheng Qiu; Simon D Message; Tatiana Kebadze; Julia Aniscenko; Peter J Barnes; Ian M Adcock; Onn M Kon; Malcolm Johnson; Marco Contoli; Luminita A Stanciu; Alberto Papi; Peter K Jeffery; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2020-04-10       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.